Retrospective study and outcome of 307 cats with feline infectious peritonitis treated with legally sourced veterinary compounded preparations of remdesivir and GS-441524 (2020–2022)
Objectives Feline infectious peritonitis (FIP) is a serious disease that arises due to feline coronavirus infection. The nucleoside analogues remdesivir and GS-441524 can be effective in its treatment, but most studies have used unregulated products of unknown composition. The aim of the present stu...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publishing
2023-09-01
|
| Sarja: | Journal of Feline Medicine and Surgery |
| Linkit: | https://doi.org/10.1177/1098612X231194460 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
